These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30706796)

  • 21. Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
    Parisi S; Ditto MC; Borrelli R; Fusaro E
    Minerva Med; 2021 Aug; 112(4):492-499. PubMed ID: 34056884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial.
    Khalaj M; Saghazadeh A; Shirazi E; Shalbafan MR; Alavi K; Shooshtari MH; Laksari FY; Hosseini M; Mohammadi MR; Akhondzadeh S
    J Psychiatr Res; 2018 Aug; 103():104-111. PubMed ID: 29807317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis.
    Steels E; Venkatesh R; Steels E; Vitetta G; Vitetta L
    Inflammopharmacology; 2019 Jun; 27(3):475-485. PubMed ID: 30927159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
    Barbierato M; Facci L; Marinelli C; Zusso M; Argentini C; Skaper SD; Giusti P
    Sci Rep; 2015 Nov; 5():16676. PubMed ID: 26578323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review.
    Davis MP; Behm B; Mehta Z; Fernandez C
    Am J Hosp Palliat Care; 2019 Dec; 36(12):1134-1154. PubMed ID: 31113223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.
    Luongo L; Guida F; Boccella S; Bellini G; Gatta L; Rossi F; de Novellis V; Maione S
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):45-54. PubMed ID: 23394524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
    Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
    Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells.
    Iuvone T; Affaitati G; De Filippis D; Lopopolo M; Grassia G; Lapenna D; Negro L; Costantini R; Vaia M; Cipollone F; Ialenti A; Giamberardino MA
    Pain; 2016 Jan; 157(1):80-91. PubMed ID: 25974242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
    Aghaei I; Rostampour M; Shabani M; Naderi N; Motamedi F; Babaei P; Khakpour-Taleghani B
    Epilepsy Res; 2015 Nov; 117():23-8. PubMed ID: 26370914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.
    Papetti L; Sforza G; Tullo G; Alaimo di Loro P; Moavero R; Ursitti F; Ferilli MAN; Tarantino S; Vigevano F; Valeriani M
    Pain Res Manag; 2020; 2020():3938640. PubMed ID: 32377286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis.
    Heide EC; Bindila L; Post JM; Malzahn D; Lutz B; Seele J; Nau R; Ribes S
    Front Immunol; 2018; 9():2671. PubMed ID: 30505308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: A meta-analysis.
    Frisaldi E; Shaibani A; Vollert J; Ferrero B; Carrino R; Ibraheem HD; Vase L; Benedetti F
    Muscle Nerve; 2019 Jun; 59(6):671-678. PubMed ID: 30883809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early effect of tacrolimus in improving excitation-contraction coupling in myasthenia gravis.
    Imai T; Tsuda E; Hozuki T; Yamauchi R; Saitoh M; Hisahara S; Yoshikawa H; Motomura M; Kawamata J; Shimohama S
    Clin Neurophysiol; 2012 Sep; 123(9):1886-90. PubMed ID: 22386321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice.
    Cristiano C; Avagliano C; Cuozzo M; Liguori FM; Calignano A; Russo R
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study.
    Noli C; Della Valle MF; Miolo A; Medori C; Schievano C;
    Vet Dermatol; 2019 Oct; 30(5):387-e117. PubMed ID: 31237065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.